Clinical trial
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
NCT02151253 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
- Lead sponsor
- Duke University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- September 30, 2015
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
daytime sleepiness, nocturia